Pascal Metrics, Inc. v. Health Catalyst, Inc.

Analysis Group was retained by Susman Godfrey on behalf of the health care analytics company Pascal Metrics, the plaintiff in a trade secret misappropriation litigation against Health Catalyst. Pascal Metrics alleged that Health Catalyst was using proprietary information supplied by former employees to build a competing product to Pascal’s Risk Trigger Monitor (RTM), a software tool used to identify patient safety concerns and adverse health events in real time and communicate them to health care professionals.

An Analysis Group team led by Managing Principal Alan White and Vice President Michael Carson supported academic affiliate Amol Navathe, who filed an expert report on whether Pascal’s designated trade secrets related to its RTM qualified as trade secrets under Delaware state code. Dr. Navathe also opined he found evidence of Health Catalyst having used Pascal’s designated trade secrets when developing its own competing products. He concluded that Pascal’s designated trade secrets did qualify as trade secrets under state code, and that Health Catalyst had used portions of those trade secrets in the development and implementation of its competing trigger-based product.

A Delaware Superior Court judge denied Health Catalyst’s motion for summary judgment, and the case settled favorably for Pascal Metrics.